Author Information
Megan Leigh Gleason Hutchcraft is currently affiliated with the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology at the University of Kentucky Markey Cancer Center, located at 800 Rose Street, Lexington, KY 40536, USA. Her research focuses primarily on gynecologic oncology, with significant contributions to ovarian cancer screening and treatment, chemotherapy-induced cognitive impairment, and the utilization of genetic screening in cancer treatment.
Research Contributions
Megan Leigh Gleason Hutchcraft has made substantial contributions to the field of gynecologic oncology. Notably, her recent work includes the significance of pelvic fluid in ovarian cancer screening, the role of the MUTYH gene as a predictive biomarker in ovarian cancer, and the cognitive effects of platinum/taxane-based chemotherapy in gynecologic cancer patients. Her research also extends to the evaluation of health-related quality of life among cancer survivors from different sexual orientations. Her multidisciplinary approach bridges clinical practice and research, aiming to enhance diagnostic and therapeutic methods in gynecologic oncology.
Aliases
Megan Leigh Hutchcraft is also known by several aliases including Megan Hutchcraft, Megan L Hutchcraft, Megan L. Hutchcraft, and Megan Leigh Gleason Hutchcraft. Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
23 |
| Citation Count |
74 |
| h-index |
5 |
